Advisory Services Network
INM icon

Advisory Services Network’s InMed Pharmaceuticals INM Stock Holding History

Advisory Services Network’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3
Closed -$25 – 2537
2023
Q4 		$25 Buy
+3
New +$29 ﹤0.01% 3830
2023
Q2 		– Hold
0
– -$6 – 2514
2023
Q1 		– Hold
0
– – – 3976
2022
Q4 		– Hold
0
– – – 3978
2021
Q3 		– Hold
0
– – – 2313
2021
Q2 		– Hold
0
– – – 3620
2021
Q1 		– Hold
0
– – – 2127
2020
Q4 		– Hold
0
– – – 3488

Other funds holding INM

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Securities
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BFSG LLC
BFSG LLC Irvine, California $1.14B AUM 21.04% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Advisornet Financial
Advisornet Financial Minnetonka, Minnesota $2.21B AUM 14.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Advisory Services Network's INM Position: Q1 2024 in Review

Advisory Services Network sold out of InMed Pharmaceuticals (INM) in Q1 2024, closing a stake of 3 shares — an estimated $25 sold.

Advisory Services Network first reported a position in INM in Q4 2023 and held it in 1 quarter. The position peaked at $25 in Q4 2023. 15 funds tracked by Wall St. Rank hold INM as of Q1 2024.

  • Advisory Services Network reported no remaining InMed Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Advisory Services Network sold 3 InMed Pharmaceuticals shares in Q1 2024, an estimated $25.
  • Advisory Services Network first reported a position in InMed Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • Advisory Services Network's InMed Pharmaceuticals position peaked at $25 in Q4 2023.
  • 15 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.